Compare

JBT Marel/$JBTM

1D1W1M3M6MYTD1Y5YMAX

About JBT Marel

JBT Marel Corp operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Protein Solutions segment includes businesses that provide solutions for the initial stage processing and harvesting of animal proteins, mainly focusing on poultry, pork, fish, and beef. The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready-to-eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical, nutraceutical, and warehouse automation end markets. The majority of its revenue is generated from the Prepared Food and Beverage Solutions segment.
Ticker
$JBTM
Primary listing
NYSE
Employees
11,500

JBT Marel Metrics

BasicAdvanced
$5.6B
29.49
$3.68
0.94
$0.40
0.37%

What the Analysts think about JBT Marel

Analyst ratings (Buy, Hold, Sell) for JBT Marel stock.
Analyst projections of the future price of JBT Marel stock.

Bulls say / Bears say

Orders topped $1 billion for a third consecutive quarter, with a 1.05 book-to-bill ratio and a $1.54 billion backlog. That provides a solid pipeline of work and visibility into near-term equipment revenue. (JBT Marel Corporation)
The combined business is beginning to show cross-selling and cost-saving potential: synergy orders reached $45 million in the first half, and management expects $60 million of realised savings in 2026. Footprint changes are also expected to generate $25 million to $30 million in annual savings by 2028. (The Motley Fool, JBT Marel Corporation)
Protein Solutions delivered strong growth, with second-quarter revenue up 11% and adjusted EBITDA margin rising 350 basis points to 24%. This profitable segment is helping offset weaker performance elsewhere. (JBT Marel Corporation)
Prepared Food and Beverage Solutions struggled to turn orders into sales: logistics constraints and production inefficiencies delayed shipments, leaving revenue flat and the segment’s adjusted EBITDA margin down 70 basis points. Management said about $20 million of revenue was delayed. (JBT Marel Corporation, The Motley Fool)
Inflation in logistics, metals and other inputs is pressuring margins, while second-quarter adjusted EBITDA included a $17 million tariff refund. Higher ongoing costs and the risk that one-off support fades could make margin improvement harder to sustain. (The Motley Fool)
A $33 million impairment tied to the Prevenio acquisition reflected customers shifting from its value-added poultry antimicrobial product towards more commodity-based demand. That raises questions about demand for some of the company’s higher-value offerings. (JBT Marel Corporation, The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 25 Oct 2026.

JBT Marel Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

JBT Marel Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing JBT Marel

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.